AllianceBernstein
ZVRA icon

AllianceBernstein’s Zevra Therapeutics ZVRA Stock Holding History

AllianceBernstein’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$584K Hold
65,190
– – ﹤0.01% 2559
2025
Q4 		$584K Sell
65,190
-5,110
-7% -$48.3K ﹤0.01% 2580
2025
Q3 		$669K Hold
70,300
– – ﹤0.01% 2535
2025
Q2 		$619K Buy
70,300
+54,200
+337% +$440K ﹤0.01% 2518
2025
Q1 		$121K Hold
16,100
– – ﹤0.01% 3036
2024
Q4 		$134K Hold
16,100
– – ﹤0.01% 3093
2024
Q3 		$112K Buy
16,100
+5,970
+59% +$40.5K ﹤0.01% 3118
2024
Q2 		$49.6K Buy
+10,130
New +$48K ﹤0.01% 3190
2022
Q2 		– Sell
-11,400
Closed -$57K – 3400
2022
Q1 		$57K Hold
11,400
– – ﹤0.01% 3168
2021
Q4 		$99K Hold
11,400
– – ﹤0.01% 3198
2021
Q3 		$106K Sell
11,400
-11,400
-50% -$115K ﹤0.01% 3180
2021
Q2 		$292K Buy
+22,800
New +$245K ﹤0.01% 3018

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return